UCI-led study finds that cancer immunotherapy may self-limit its efficacy ...Middle East

News by : () -
Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy in fighting tumors, according to a new study led by Francesco Marangoni, Ph.D., assistant professor of physiology & biophysics and member of the Institute for Immunology at the University of California, Irvine. Study results are published online in the journal Cell.

Hence then, the article about uci led study finds that cancer immunotherapy may self limit its efficacy was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( UCI-led study finds that cancer immunotherapy may self-limit its efficacy )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار